Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes (Q43236097)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2008
edit
Language Label Description Also known as
English
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
scientific article published in September 2008

    Statements

    Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes (English)
    1 reference
    J-P Courrèges
    1 reference
    T Vilsbøll
    1 reference
    M Zdravkovic
    1 reference
    T Le-Thi
    1 reference
    T Krarup
    1 reference
    O Schmitz
    1 reference
    R Verhoeven
    1 reference
    I Bugáñová
    1 reference
    1 September 2008
    1 reference
    25
    1 reference
    9
    1 reference
    1129-1131
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit